Follow the people · Insider
Wayne Markowitz
Wayne Markowitz files insider transactions with the SEC as a cvp, japac of Edwards Lifesciences (EW). We hold 4 disclosed purchases and sales filed since 15 September 2023, 3 of them in the last 90 days.
- Files forEW
- Disclosed buys and sells4 in all, 3 in the last 90 days
- Last disclosure26 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 14 September 2023 — 26 August 2026Cvp, Japac · Edwards Lifesciences (EW)26 Form 4 lines · source: SEC Form 4
Everything they disclosed
26 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 1,240 shares of Edwards LifesciencesSEC Form 426 August 2026Common Stock · traded 26 August 2026 · filed 26 August 2026
- ▼ sold on the open market 146 shares of Edwards LifesciencesSEC Form 430 July 2026Common Stock · traded 30 July 2026 · filed 30 July 2026
- exercised options over 9,628 shares of Edwards LifesciencesSEC Form 428 July 2026Common Stock · traded 28 July 2026 · filed 28 July 2026
- ▼ sold on the open market 9,628 shares of Edwards LifesciencesSEC Form 428 July 2026Common Stock · traded 28 July 2026 · filed 28 July 2026
- exercised options over 9,628 shares of Edwards Lifesciences (a derivative holding)SEC Form 428 July 2026Employee Stock Option (Right to Acquire) · traded 28 July 2026 · filed 28 July 2026
- was granted 5,200 shares of Edwards LifesciencesSEC Form 411 May 2026Common Stock · traded 7 May 2026 · filed 11 May 2026
- had shares withheld for tax on 264 shares of Edwards LifesciencesSEC Form 411 May 2026Common Stock · traded 7 May 2026 · filed 11 May 2026
- had shares withheld for tax on 226 shares of Edwards LifesciencesSEC Form 411 May 2026Common Stock · traded 8 May 2026 · filed 11 May 2026
- ▼ sold on the open market 593 shares of Edwards LifesciencesSEC Form 411 May 2026Common Stock · traded 11 May 2026 · filed 11 May 2026
- was granted 26,400 shares of Edwards Lifesciences (a derivative holding)SEC Form 411 May 2026Employee Stock Option (Right to Acquire) · traded 7 May 2026 · filed 11 May 2026
- was granted 5,200 shares of Edwards Lifesciences (a derivative holding)SEC Form 411 May 2026Performance Rights · traded 7 May 2026 · filed 11 May 2026
- ▼ sold on the open market 583 shares of Edwards LifesciencesSEC Form 48 December 2025Common Stock · traded 8 December 2025 · filed 8 December 2025
- was granted 6,410 shares of Edwards LifesciencesSEC Form 415 September 2025Common Stock · traded 11 September 2025 · filed 15 September 2025
- had shares withheld for tax on 650 shares of Edwards LifesciencesSEC Form 415 September 2025Common Stock · traded 14 September 2025 · filed 15 September 2025
- was granted 17,100 shares of Edwards Lifesciences (a derivative holding)SEC Form 49 May 2025Employee Stock Option (Right to Acquire) · traded 8 May 2025 · filed 9 May 2025
- was granted 3,350 shares of Edwards Lifesciences (a derivative holding)SEC Form 49 May 2025Performance Rights · traded 8 May 2025 · filed 9 May 2025
- ▼ sold on the open market 268 shares of Edwards LifesciencesSEC Form 49 May 2025Common Stock · traded 7 May 2025 · filed 9 May 2025
- had shares withheld for tax on 300 shares of Edwards LifesciencesSEC Form 49 May 2025Common Stock · traded 7 May 2025 · filed 9 May 2025
- was granted 3,350 shares of Edwards LifesciencesSEC Form 49 May 2025Common Stock · traded 8 May 2025 · filed 9 May 2025
- ▼ sold on the open market 583 shares of Edwards LifesciencesSEC Form 46 December 2024Common Stock · traded 6 December 2024 · filed 6 December 2024
- had shares withheld for tax on 648 shares of Edwards LifesciencesSEC Form 416 September 2024Common Stock · traded 14 September 2024 · filed 16 September 2024
- was granted 17,800 shares of Edwards Lifesciences (a derivative holding)SEC Form 49 May 2024Employee Stock Option (Right to Acquire) · traded 7 May 2024 · filed 9 May 2024
- was granted 3,350 shares of Edwards Lifesciences (a derivative holding)SEC Form 49 May 2024Performance Rights · traded 7 May 2024 · filed 9 May 2024
- was granted 3,350 shares of Edwards LifesciencesSEC Form 49 May 2024Common Stock · traded 7 May 2024 · filed 9 May 2024
- was granted 19,256 shares of Edwards Lifesciences (a derivative holding)SEC Form 415 September 2023Employee Stock Option (Right to Acquire) · traded 14 September 2023 · filed 15 September 2023
- was granted 7,262 shares of Edwards LifesciencesSEC Form 415 September 2023Common Stock · traded 14 September 2023 · filed 15 September 2023
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.